IDEXX Laboratories Inc. closed 30.43% below its 52-week high of $548.88, which the company reached on May 15th.

Shares of IDEXX Laboratories Inc. IDXX slipped 4.74% to $361.04 Tuesday, on what proved to be an all-around grim trading ...

IDEXX Laboratories, Inc. IDXX is well-poised to grow in the upcoming quarters due to the performance of its CAG (Companion Animal Group) Diagnostics business. The consistent growth in ...

In a report released yesterday, Mark Massaro from BTIG reiterated a Buy rating on Idexx Laboratories (IDXX – Research Report), with a price target of $530.00. The company’s shares closed ...

Idexx Laboratories has steadily increased its scale and reach in the veterinary diagnostic lab business to dig a wide moat. It is well-positioned to benefit from two key trends. First, pet ...

Upgraded IDEXX to 'Buy' with a $450 price target due to oncology business expansion and share repurchase program. IDEXX's oncology market entry with Cancer Dx panel in March 2025 could drive ...

MLB, Topps and Nike have partnered to recognize baseball's elite performers from last season with custom gold-embellished MLB logos on their jerseys that will then be used to create trading cards.

The pet care industry is growing, with increasing pet ownership and spending, especially in emerging markets, providing IDEXX with significant growth opportunities. IDEXX Laboratories is the ...